But surprisingly, the high expression of ACSL4 in HCC implies that hepatocellular carcinoma is highly sensitive to ferroptosis, and thus inducing hepatocellular carcinoma cells to target ferroptosis is a new direction for precision tumor therapy (Grube et al. 2022). This evidence concerns the gene ACSL4 and neoplasm.